It is, what it is.
Recent MBOT News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 12:30:24 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/15/2024 12:40:29 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/15/2024 12:40:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 12:38:15 PM
- Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 • GlobeNewswire Inc. • 10/15/2024 12:38:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 08:30:20 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/01/2024 12:10:21 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/01/2024 12:07:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 12:33:51 PM
- Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up • GlobeNewswire Inc. • 09/30/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 12:30:27 PM
- Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System • GlobeNewswire Inc. • 09/17/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 05:00:40 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/22/2024 03:36:31 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/22/2024 03:33:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2024 12:30:38 PM
- Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System • GlobeNewswire Inc. • 08/22/2024 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/15/2024 11:34:05 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/15/2024 11:32:11 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 05:15:42 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/13/2024 08:30:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/13/2024 08:30:46 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/13/2024 08:30:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:30:38 PM
- Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization • GlobeNewswire Inc. • 08/13/2024 12:30:00 PM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM